Company Enzymes & Derivates Sa with Fiscal Code 6192045
recorded a turnover of 2024 of
5.401.424,
with a net profit of
73.732
and having an average number of employees of
13.
The company operates in the field of Intermedieri în comerţul cu produse diverse having the NACE code 4619.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Enzymes & Derivates Sa
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
3.745.209
3.655.793
4.019.902
3.839.788
3.543.122
3.572.335
3.826.477
4.382.116
4.960.249
5.401.424
Total Income - EUR
3.781.088
3.686.340
4.050.839
3.858.702
3.603.333
3.595.281
3.864.756
4.408.272
4.995.096
5.432.137
Total Expenses - EUR
3.724.204
3.606.945
3.960.392
3.728.779
3.519.207
3.456.636
3.653.767
4.220.850
4.916.930
5.332.110
Gross Profit/Loss - EUR
56.884
79.395
90.447
129.924
84.126
138.645
210.990
187.422
78.166
100.028
Net Profit/Loss - EUR
44.507
57.747
65.263
102.360
61.400
113.895
172.051
153.845
55.623
73.732
Employees
21
21
21
21
17
14
14
12
14
13
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 9.5%, from 4.960.249 euro in the year 2023, to 5.401.424 euro in 2024.
The Net Profit increased by 18.420 euro, from 55.623 euro in 2023, to 73.732 in the last year.
Check the financial reports for the company - Enzymes & Derivates Sa
Financial Rating - ENZYMES & DERIVATES SA
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Enzymes & Derivates Sa
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Enzymes & Derivates Sa
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Enzymes & Derivates Sa
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Enzymes & Derivates Sa - CUI 6192045
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
44.007
36.364
33.980
44.469
83.940
101.230
134.936
127.331
125.951
99.361
Current Assets
1.288.304
1.230.281
1.365.515
1.481.190
1.186.837
1.246.747
1.280.821
1.418.556
1.503.536
1.617.864
Inventories
265.585
287.950
260.599
283.559
218.440
288.225
234.480
252.457
262.029
291.120
Receivables
1.021.798
966.385
1.164.921
1.256.888
1.028.900
997.695
1.036.032
1.159.001
1.193.708
1.454.306
Cash
921
-24.054
-60.005
-59.256
-60.503
-39.173
10.310
7.098
47.800
-127.562
Shareholders Funds
675.515
704.345
757.782
795.204
615.427
694.810
802.667
780.373
833.629
902.702
Social Capital
33.746
33.402
32.836
64.468
30.345
29.770
29.110
29.200
29.111
28.949
Debts
656.796
562.300
641.713
730.455
655.350
653.166
613.090
765.514
795.858
814.523
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4619 - 4619"
CAEN Financial Year
4619
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
1.617.864 euro in 2024 which includes Inventories of
291.120 euro, Receivables of
1.454.306 euro and cash availability of
-127.562 euro.
The company's Equity was valued at
902.702 euro, while total Liabilities amounted to
814.523 euro.
Equity increased by 73.732 euro, from 833.629 euro in 2023, to 902.702 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Enzymes & Derivates Sa